webinar register page

Webinar banner
BioInvent KOL Call: BI-1206 for Relapsed or Refractory Non-Hodgkin's Lymphoma


Jan 28, 2021 11:10 AM

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Mats Jerkeman, MD
@Lund University
Dr. Mats Jerkeman is Professor in Clinical Oncology at Lund University, Sweden. His research focus is all possible aspects of malignant lymphomas, aiming for the improvement of the quality of life and survival of these patients. Dr. Jerkeman is the coordinator of several ongoing clinical trials in diffuse large B-cell lymphoma and mantle cell lymphoma. He also serves as Chairman of the Nordic Lymphoma Group, Editor of ESMO Guidelines/Lymphoma and as coordinator of the Swedish Lymphoma Register for many years.